Home » Trials » SLCTR/2015/012 » Progress Reports


Trials - SLCTR/2015/012

Progress Report

Date Modified

2019-07-09


Period

24/months


Report Summary

The temporal distribution patterns of WBC, platelets, serum albumin and serum cholesterol were higher, while PCV, serum AST and ALT levels were lower in the treatment group compared to placebo. PCV on day 3.5, WBC on day 6, ALT on day 4 and 5, AST on day 3 to 5 and albumin on day 5 were significantly improved in the treatment group. There was no difference in the duration of hospital stay or occurrence of leaking. However, the duration of leaking was significantly lower in the treatment group.


Attached file